NEVVI Medicare utilization intelligence
or

← back

Provider profile

RIZVI, AKBAR MD

Hematology-Oncology · NPI 1225023948 · MCKINNEY, TX

1
Groups
47
Codes · 2024
90,087
Disclosed services

RIZVI, AKBAR is a Hematology-Oncology in MCKINNEY, TX, a member of 1 medical group, who billed 47 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

90,087
disclosed services
47
codes billed to Medicare Part B
Prior year · CY2023 94,092 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1453 Injection, fosaprepitant, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9267 Injection, paclitaxel, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
J1626 Injection, granisetron hydrochloride, 100 mcg
J9190 Injection, fluorouracil, 500 mg
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J3489 Injection, zoledronic acid, 1 mg
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J3490 Unclassified drugs
82378 Carcinoembryonic antigen (cea) protein level
J7030 Infusion, normal saline solution , 1000 cc
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
85055 Reticulated (young) platelet measurement
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96374 Injection of drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82565 Blood creatinine level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.